Postes actifs de Mitchell Barneck
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Light Line Medical, Inc.
 Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Directeur/Membre du Conseil | - | - |
| Fondateur | - | - | |
| Corporate Officer/Principal | - | - |
Historique de carrière de Mitchell Barneck
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Health Technology |
- Bourse
- Insiders
- Mitchell Barneck
- Expérience
